EBPG-Europe
November
2002 |
- CRP
testing should be included in the routine risk evaluation in
stable patients. Measurements should be done at least in 3
monthly intervals.
- When CRP >8mg/l screening should be done for silent infection
of access grafts, paradontitis or any low-grade infection.
- When CRP >8mg/dl biocompatibility and haemodialysis fluid
should be checked. |
VII.5 Microinflammatory state |
Evidence
level B
Evidence level B
Evidence level B
|